TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from cbdMD ( (YCBD) ) is now available.
cbdMD, Inc. announced the appointment of T. Ronan Kennedy, its current CEO and CFO, to the Board of Directors, expanding it to five members. Under Kennedy’s leadership, the company has stabilized, optimized its cost structure, and improved operational fundamentals, positioning itself for long-term success. His appointment is expected to enhance the company’s strategic capabilities and shareholder value.
More about cbdMD
cbdMD, Inc. is a prominent CBD company known for its highly trusted and recognized cannabidiol (CBD) brands, including cbdMD and Paw CBD. The company offers a wide range of U.S.-produced, THC-free CBD products, such as tinctures, gummies, topicals, capsules, and more, as well as veterinarian-formulated pet products. Additionally, cbdMD’s ATRx Labs brand focuses on natural functional mushroom support.
YTD Price Performance: -65.38%
Average Trading Volume: 355,063
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.99M
For an in-depth examination of YCBD stock, go to TipRanks’ Stock Analysis page.